Introduction {#S1}
============

Bivalve mollusk culture is an important sector of world aquaculture, representing approximately a fifth of the global production with 15.7 million tons harvested in 2017 ([@B34]). Given the economic scale and growing importance as a food source for the human population of bivalve farming, much interest has been devoted to investigate infectious diseases, representing a main limitation for aquaculture expansion ([@B74]; [@B58]; [@B17]). Among pathogens, viruses represent major risks for the sustainable management of this sector, as some viruses are highly infectious, easily transmissible, and bear a high extinction potential ([@B37]). In particular, in the 1970s, an infection with an iridovirus completely decimated the population of *Crassostrea angulata* oysters, then cultivated on all European coasts ([@B25]; [@B66]; [@B4]). Currently, the Ostreid-1 herpesvirus (OsHV-1) is recognized as being responsible for sporadic mortalities in several bivalve mollusks but it is one of the main mortality threats for the most cultivated bivalve species, the Pacific oyster *Crassostrea gigas* ([@B5]; [@B64]; [@B27]; [@B26]; [@B73]; [@B79]; [@B17]). In this bivalve species, OsHV-1 triggers the Pacific oyster mortality syndrome (POMS) that has plagued the oyster production worldwide, from Europe to north and south America and Asia, for more than a decade ([@B57]; [@B39]; [@B40]; [@B12]; [@B54]; [@B63]; [@B21]). This syndrome, affecting juveniles, leads to mass mortalities that can reach 100% within days ([@B72]). Research efforts have revealed a series of factors contributing to the disease, including infectious agents interacting with seawater temperature and oyster genetics ([@B72]; [@B57]; [@B60]; [@B33]; [@B59]; [@B46]; [@B9]). Recently, holistic molecular approaches uncovered the pathogenis associated to POMS ([@B28]). These studies showed that an infection by a variant of OsHV-1 (Oyster herpesvirus type 1 variant μVar) is the critical step of the infectious process leading to an immune-compromised state followed by a microbiota destabilization that "opens the door" to bacterial pathogens (e.g., vibrios) that target haemocytes to induce their lysis ([@B71]). The infectious process is completed with subsequent bacteraemia ultimately leading to oyster death ([@B28]).

Although the first description of herpes-like viral infection in oyster (*Crassostrea virginica*) was reported in 1972 by Farley and collaborators ([@B35]), it was not until the 2000s that partial genome characterization allowed the identification of Ostreid herpesvirus 1 (OsHV-1), a new viral species infecting Pacific oyster larvae and spats ([@B45]). The first variants of the virus identified, called OsHV-1 var, were associated with mortalities in *C. gigas* and other mollusks; they notably carried a deletion of 2.8 kpb as compared to the previous, not fully assembled, OsHV-1 genome ([@B7]). The genome of OsHV-1 has been fully sequenced from oyster larvae in 2005 and contains a double strand DNA genome of ∼207 kbp encoding approximately 124 open reading frames (ORFs) ([@B27]). Then in 2008, an emergent genotype, called OsHV-1 μVar, was characterized. It was associated with higher mortalities ([@B72]) and several variants of μVar genotype have been identified over the last decades (reviewed in [@B73]).

The OsHV-1 μVar genotype has a 12 bp deletion in a microsatellite locus upstream of ORF4, indel/substitution in ORFs 4/42/43, and a complete loss of ORFs 36/37 as well as partial loss of ORF 38 ([@B72]; [@B65]; [@B51]). Over the past 5 years, with the increasing use of sequencing technologies, more and more genotypes were identified such as OsHV-1-SB ([@B79]) OsHV-1 μVar A and B genotypes with insertion of 4 ORFs including one coding a membrane protein ([@B18]) OsHV-1-PT from the North Adriatic Sea ([@B1]) and OsHV-1 isolate ZK0118 ([@B11]). In addition, PCR amplification of a subset of ORFs allowed the screening of new genotypes ([@B20]). This expanding number of OsHV-1 genotypes and number of carrier species ([@B5], [@B6], [@B8]; [@B13]; [@B12]) raises the question of the impact of this genetic diversity on spreading and severity of POMS.

Accumulating research over the past decades have shown that a large number of viruses exhibit a high level of genetic diversity. This is especially true for viruses with RNA genomes, including medically important viruses such as HIV, hepatitis C virus, and influenza; this is largely due to the low fidelity of their viral RNA-dependent RNA polymerase (RdRp) ([@B32]; [@B55]). Extensive study of this diversity has led to the development of the quasispecies concept that questioned our current understandings of viral diseases and their evolution ([@B14]; [@B76]; [@B44]). It seems that many viruses have the ability to produce diverse genetically linked mutants that can be defined as viral populations or quasispecies maintained by mutation-selection equilibrium ([@B56]; [@B62]). This concept hypothesizes that dynamic viral populations generate beneficial interactions and cooperation that allows them to rapidly adapt to changing environments, including various hosts and their different tissues, relevant for viral fitness and virulence ([@B80]; [@B16]). Studies have shown that the level of genetic diversity within viral populations likely influences viral pathogenicity, dissemination and host immune evasion ([@B50]). Conversely, limited diversity could strongly attenuate virulence ([@B61]). DNA viruses also bear genomic variability that rivals that of many RNA viruses ([@B68]; [@B67]). Recent work has shown a significant inter-host and intra-host genetic divergence across tissue compartments and time of infection by herpesviruses ([@B69], [@B70]). In addition, the evolution of a disease is sometimes not fully explained by intrinsic factors of the host, but rather by the variability of herpesvirus ([@B2]).

Up to now, far too little attention has been paid to the role of OsHV-1 genetic diversity in POMS. Here, we analyzed a set of biparental oyster families displaying contrasting susceptibility phenotypes to POMS in two different infectious environments. This biological material gave us the unique opportunity to explore the impact of the genetic diversity of OsHV-1 μVars on the outcomes of the disease for different oyster genotypic backgrounds. We found that susceptibility phenotypes of oyster families varied from one infectious environment to another. Single Nucleotide Polymorphism (SNP) exploration from RNAseq data revealed different viral populations in the different infectious environments; these viral populations were different from the reference OsHV-1 μVar genome. Moreover, in a same infectious environment, the different oyster families were shown to be infected by different OsHV-1 variants. The genetic diversity of viruses between oyster families and environments suggests a host-pathogen co-evolutionary process. Interestingly, viral populations contain protein-coding variations that might impact viral pathogenesis, as revealed by SNPs localization. This work advances our knowledge of OsHV-1 μVar diversity and constitutes a step toward future investigation on the role of viral genetic variation, its relationship with phenotype, host genetics, and impact on disease outcome.

Materials and Methods {#S2}
=====================

Production of Biparental Oyster Families {#S2.SS1}
----------------------------------------

Biparental oyster families were produced by *in vitro* fertilization from wild genitors sampled in farming and non-farming areas as previously described ([@B28], [@B29]). Briefly, wild genitors used to produce Atlantic families F9 and F11 were collected at two sites approximately 20 km apart, in Logonna Daoulas (lat.: 48.335263 long.: -4.317922, farming areas) and Dellec (lat.: 48.353970 long.: -4.566123, non-farming areas), respectively ([Figure 1A](#F1){ref-type="fig"}). Wild genitors used to produce Mediteranean families F32 and F44 were collected at two sites approximately 40 km apart, in Vidourle (lat.: 43.553906 long.: 4.095175, non-farming areas) and Thau lagoon (lat.: 43.418736 long.: 3.622620, farming areas), respectively. Genitors coming from aquaculture areas were assumed to be exposed to stronger selection pressure due to mass mortality outbreaks occurring annually at these sites. The last family, F21, was generated from a pair of broodstocks derived from mass selection conducted in the field during four generations in an aquaculture area at the Atlantic coast (La Tremblade, lat 45.781741 long -1.12191) ([@B30]).

![Broodstock origins for the production of biparental oyster families and schematic of experimental infection. **(A)** Wild stocks were sampled in farming (red) and non-farming (green) sites in two geographic areas (Atlantic and Mediterranean coasts). Mass selected oysters (blue) originated from the Ifremer hatchery of La Tremblade. Image source: commons.wikimedia.org. **(B)** For experimental infection, pathogen free oysters were deployed in the natural environment in a farming area during disease outbreaks and brought back to a controlled environment to transfer the disease to each oyster families under controlled conditions. Experimental infections were performed with infectious environments from Atlantic and Mediterranean origin. This figure was adapted from [@B29] ([(https://doi.org/10.1186/s12864-020-6471-](https://doi.org/10.1186/s12864-020-6471-)).](fmicb-11-01579-g001){#F1}

Experimental Infections {#S2.SS2}
-----------------------

Our experimental infection protocol consists of a cohabitation between *C. gigas* oysters ("donors") carrying the disease and "pathogen-free" *C. gigas* oysters ("recipients") ([@B60]; [@B28]). The "pathogen-free" status of the animals was confirmed by (i) the absence of OsHV-1 DNA detection by qPCR and (ii) a low Vibrio presence (∼10 cfu^--1^ tissue) determined by isolation on selective culture medium (thiosulfate-citrate-bile salts-sucrose agar, TCBS). Oysters were observed to remain free of any abnormal mortality throughout the larval stage until the beginning of the experimental infections. A first experimental infection used donors previously exposed to the infectious environment of Atlantic origin. The donors were "pathogen-free" oysters (mixture of 116-day-old oysters from the 15 families, 17,700 g with a mean individual weight of 1.1 g) were first deployed in a farming area (Logonna Daoulas, lat 48.335263, long - 4.317922) during the infectious period until the first mortalities occurred. Then, donor oysters were transferred back to the laboratory and placed in contact with "pathogen-free" recipient oysters in a controlled environment ([Figure 1B](#F1){ref-type="fig"}). The experiment was conducted using the same biomass (1120 g) of donors in cohabitation in independent tanks, each containing one of the recipient oyster families (1120g with a mean individual weight of 1.1 g) which were previously acclimatized in these structures for 2 weeks. The Atlantic experimental infection began on 17 July 2015 and ended on 31 July 2015. Similarly, a second experimental infection used donors previously exposed to the infectious environment of Mediterranean origin in a farming area (Thau lagoon, lat 43.418736, long 3.622620), except that donors deployed were a mixture of 176-day-old oysters from the 15 families (26,500 g with a mean individual weight of 1.7 g) and that the biomass of donors and the biomass of recipients in each tank was 1760 g each (recipient oysters with a mean individual weight of 1.73 g). The Mediterranean experimental infection began on 21 September 2015 and ended on 6 October 2015. In parallel and for each experimental infection, a control cohabitation experiment was performed under identical conditions but using donors that had not spent time in the farming areas. Mortality was monitored in laboratory tanks. During the experimental infection, 10 oysters in triplicate were randomly sampled without blinding protocols from each tank and at each time point (0, 6, 12, 24, 48, 60, and 72 h). The shell was removed, and pools of 10 oysters were flash frozen in liquid nitrogen.

DNA and RNA Extractions {#S2.SS3}
-----------------------

Oyster pools (10 individuals per pool) were ground in liquid nitrogen in 50 mL stainless steel bowls with 20 mm diameter grinding balls (Retsch MM400 mill). The obtained powders (stored at −80°C) were then used for extraction of DNA and RNA as previously described in [@B28]. Briefly, DNA and RNA were extracted using the NucleoSpin^®^ Tissue Genomic extraction kit (Macherey-Nagel) and the Direct-Zol RNA Miniprep kit (Proteigene), respectively, according to the manufacturer's protocol. Nucleic acids concentration and purity were checked using a NanoDrop ND-1000 spectrometer (Thermo Scientific), and their integrity was analyzed by capillary electrophoresis on a BioAnalyzer 2100 (Agilent).

Viral Load Quantification {#S2.SS4}
-------------------------

Quantification of OsHV-1 has been carried out using quantitative PCR (qPCR) and used as a proxy for infection. All amplification reactions have been analyzed using the Roche LightCycler 480 Real-Time thermocycler in three technical replicates (qPHD-Montpellier GenomiX platform, Montpellier University, France). The total qPCR reaction volume was 1.5 μL, consisting of 0.5 μL of DNA (40 ng/μL) and 1 μL of LightCycler 480 SYBR Green I Master mix (Roche) containing 0.5 μM of PCR primer (Eurogenetec SA). Virus-specific primer pairs target the region of the OsHV-1 genome predicted to encode a catalytic subunit of DNA polymerase (ORF100, AY509253): Fw-5′-ATTGATGATGTGGATAATCTGTG-3′ and Rev-5′-GGTAAATACCATTGGTCTTGTTCC-3′ ([@B77]). A Labcyte Acoustic Automated Liquid Handling Platform (ECHO) has been used for pipetting into the 384-well plate (Roche). A LightCycler^®^ 480 Instrument (Roche) was used for qPCR with the following program: enzyme activation at 95° C for 10 min followed by 40 denaturation cycles (95° C, 10 s), hybridization (60° C, 20 s) and elongation (72° C, 25 s). To check the specificity of the amplification, a subsequent melting temperature curve of the amplicon was performed. For absolute quantification, DP amplification products were cloned into the pCR4-Topo vector and replicated in *Escherichia coli* DH5α (Invitrogen). Plasmids were extracted using the Wizard Plus SV miniprep DNA purification system (Promega) and standard curves of known concentration of plasmid generated according to the following formula \[amount of plasmid DNA (ng) × 6.022.10^23^\]/\[length of DNA template (bp) × 10^9^ × 660\]. Absolute quantification of viral DNA copies was then calculated by comparing the reported Cq values to the standard curve constituted of 8 serial dilution points of the circular plasmid (10^9^--10^2^ copies per μL) in three technical replicates (*R*^2^ = 0.993, efficiency = 1.91 and equation: y = -3.5416x + 40.02). Samples were considered positive when superior to 10^2^ copies per μL (corresponding to 30 cycles) and but also when inferior to 10^2^ copies per μL if the melting temperature of amplicon was correct (between 30 and 35 cycles).

RNA-Seq Analyses {#S2.SS5}
----------------

RNA-Seq library construction and sequencing were performed by the Fasteris Company (Switzerland). Directional cDNA libraries were constructed using a TruSeq mRNA Stranded kit (Illumina) and sequenced on a Hiseq in paired-end reads of 2 × 75 bp. Adapters were cleaned using trimmomatic 0.39 ([@B15]). The quality of the sequences was evaluated by FastQC v0.11.8 ([@B3]) and reads with a mapping quality above 20 were retained. PCR duplicates from sequencing where remove using picard v2.18.14 ("Picard toolkit," 2019)^[1](#footnote1){ref-type="fn"}^ with the MarkDuplicates option. Then reads were aligned to the OsHV-1 μVar A genome (GenBank: KY242785.1) ([@B18]) using Bowtie 2 v2.3.4.3 ([@B42]). The abundance of OsHV-1 μVar reads was counted using samtools v1.9 ([@B48]) and normalized by multiplying raw mapped reads on the OsHV-1 μVar A genome by a library normalization factor (calculated as the average library size for all times and controls divided by the library size for the specific time point) ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}). The abundance of OsHV-1 μVar reads was used as a proxy for viral replication. Data treatments were carried out under a High-performance computing (HPC) cluster using a self-scripted pipeline (code including parameters used are available on <https://github.com/IHPE/DivOsHV>).

SNP Calling and Quantification {#S2.SS6}
------------------------------

SNP detection and quantification were performed on families F11 and F32 in both the Atlantic and Mediterranean experimental infections, while families F9 and F44 were only analyzed in the Atlantic experimental infections due to the lower read coverage in the Mediterranean infections. Sequencing reads were mapped to OsHV-1 μVar A genome as described previously. Because the sequencing depths differ between time-points and according to the sensitivities of infected oysters, we first concatenated the three replicates of the three time-points containing the highest viral loads together (48, 60, and 72 h) using samtools merge v1.9 ([@B48]). Then pysamstats v1.1.2^[2](#footnote2){ref-type="fn"}^ was used to count the nucleotide composition on all genomic positions. SNPs were detected with an *ad hoc* script^[3](#footnote3){ref-type="fn"}^, using the R language R Core Team, applied to each pysamstats output. Nucleotide changes were called "SNP" if (i) the alternative base frequency was greater than 5%. (ii) the sequencing depth was greater than 180 reads, to insure an average coverage of 60 for the triplicates. (iii) the depth of the alternative base was greater than an intrinsic parameter to the library (mean + standard deviation of all alternative bases) which is used to eliminate all low abundant alternative bases. The outputs were stored in VCF format which allow us to determine the impact of each SNP with SnpEff and SnpSift ([@B24]). Finally, to compare the environments, we combined the data according to the experimental infection origin. SNP counts were summed by family and allelic frequency recalculated using R. All the graphics were made using the ggplot2 package ([@B78]) and Venn diagrams were made with the Venn Diagram package ([@B23]).

Statistical Analysis {#S2.SS7}
--------------------

OsHV-1 colonization was assessed before the first mortalities appear, at 12/24/48/60/72 h post-infection. For the statistical analyzes, the time points were subdivided into two groups, the first one corresponded to the early stage of the infection (12/24 h) that is characterized by an intense increase of the viral load, whereas the second one corresponded to the late stage of the infection (48/60/72 h) when viral load reached a plateau. Mann--Whitney *U*-tests were used (GraphPad Prism 8.4.2) to compare OsHV-1 load and replication rate between families at late phase of the infection (48/60/72 h) ([Supplementary Table S2](#TS2){ref-type="supplementary-material"}). Mann--Whitney *U*-tests were also used to compare OsHV-1 viral load within each family between early and late phase ([Supplementary Table S2](#TS2){ref-type="supplementary-material"}).

Results {#S3}
=======

Susceptibility of Oyster Families to POMS Is Associated With Viral Load and Varies According to Disease Origin {#S3.SS1}
--------------------------------------------------------------------------------------------------------------

In this study, we used five biparental families of juvenile oysters with contrasting phenotypes toward POMS. These families were produced from genitors that had experienced different selective filters (see "Materials and Methods" section). The 5 families were subjected to an experimental infection mimicking disease transmission in nature. For that we performed cohabitation experiments with oysters previously immersed in Atlantic and Mediterranean oyster farms during POMS events (see [Figure 1B](#F1){ref-type="fig"} and "Materials and Methods" section).

A high variability in survival rates was observed between families within each experimental infection, ranging from 1 to 98% and 10 to 99.7% in Atlantic and Mediterranean experimental infection, respectively ([Figures 2A,B](#F2){ref-type="fig"}). Two families, F11 and F21, had the same phenotypes, susceptible (S, percentage of survival \< 25%) and resistant (R, percentage of survival \> 75%), respectively, whatever the experimental infection they faced (Atlantic or Mediterranean). Conversely, the phenotype of the three other families changed with experimental infections. Oyster families F9, F32, and F44, which had an intermediate phenotype (I, 25% ≤ percentage of survival ≥ 75%) in the Atlantic experimental infection (Atl), were found susceptible (F32) or resistant (F9 and F44) in the Mediterranean experimental infection (Med). These phenotypic changes cannot be attributed to a decrease in the severity of POMS in Med since (i) the F11 family had almost the same survival rate in both experimental infections and (ii) the F32 family has a lower survival rate in Med than in Atl.

![Survival curves and OsHV-1 colonization of five biparental oyster families submitted to experimental infections using donors oysters deployed in Atlantic and Mediterranean farming area during infectious period. **(A,B)** Represent Kaplan-Meier survival curves of the 5 families of recipient oysters during the Atlantic and Mediterranean natural experimental infection, respectively. Resistant, intermediate and susceptible oyster families are indicated by R, I and S, respectively. The stars indicate *P*-values according to Mantel-Cox Log-rank test (^∗^*P* ≤ 0.05, ^∗∗∗^*P* ≤ 0.001). OsHV-1 colonization was assessed at the early time point of experimental infection at 12/24/48/60/72 h. **(C,D)** OsHV-1 load was quantified by qPCR and expressed as viral gene copy number per ng of oyster DNA. **(E,F)** Viral replication was estimated by the total number of RNA-Seq reads mapped on the OsHV-1 μVar A genome (KY242785). The stars indicate *P*-value according to Mann-Whitney multiple comparisons *U*-tests of viral load **(C,D)** and viral replication rate **(E,F)** between families at late phase of infection (48/60/72 h) (^∗∗∗^*P* ≤ 0.001 ^\*⁣\*⁣\*\*^*P* ≤ 0.0001).](fmicb-11-01579-g002){#F2}

The load and transcriptional activity of OsHV-1 μVar were monitored within the first 72 h post-infection in the five oyster families and two experimental infections (Atl and Med) using qPCR and RNA-Seq, respectively ([Figures 2C--F](#F2){ref-type="fig"}). In all conditions we observed that the viral loads significantly increased between the early (12/24 h) and the late (48/60/72 h) phase of infection ([Figures 2C,D](#F2){ref-type="fig"}; Mann--Whitney *U*-test, *P* \< 0.01 in Atl and *P* \< 0.001 in Med; details in [Supplementary Table S2](#TS2){ref-type="supplementary-material"}). We also detected viral transcripts in both experimental infections for all oyster families ([Figures 2E,F](#F2){ref-type="fig"}). These results show that OsHV-1 was able to infect all oyster families, indicating all were tolerant to infection. However, the amount of viral nucleic acid varied with disease expression: susceptible families accumulated 10^2^--10^3^ times more viral transcripts than resistant ones ([Supplementary Table S3](#TS3){ref-type="supplementary-material"}). Taken together, these results show that all families were infected with the OsHV-1 μVar virus but the most resistant ones controlled viral replication.

Noteworthy, oyster families with an intermediate phenotype in Atl showed an R or S phenotype in Med. As the major difference between these two experiments is the geographic origin of the infection, it suggests that the POMS occurring on the Atlantic coast is different from that of the Mediterranean coast. This difference in survival phenotypes is also visible at the late phase of infection (48/60/72 h) both in terms of viral load and viral replication rate. Indeed, in Atl, viral load and viral replication rate are not significantly different for the three intermediate phenotype families (F9, F32, and F44, Mann--Whitney *U*-test, *P* \> 0.05) ([Figures 2C--E](#F2){ref-type="fig"} and [Supplementary Table S2](#TS2){ref-type="supplementary-material"}). Conversely, in Med, the viral load and replication rate are significantly different between the three families (Mann--Whitney *U*-test, *P* \< 0.001) ([Figures 2D--F](#F2){ref-type="fig"} and [Supplementary Table S2](#TS2){ref-type="supplementary-material"}). These observations led us to hypothesize that oysters encountered different OsHV-1 μVar populations in the two environments.

Two Distinct Viral Populations in Atlantic and Mediterranean Infections Revealed by SNPs {#S3.SS2}
----------------------------------------------------------------------------------------

Viral populations present in the Atlantic and Mediterranean environments, were analyzed by merging RNA-Seq data according to environments. This included the RNA-Seq reads mapping against OsHV-1 μVar A genome in the 3 replicates and the 3 time points containing the highest viral loads (48, 60, and 72 h), both in intermediate and susceptible families (resistant families were not included in the analyses due to the low number of viral reads). Then, single nucleotide polymorphisms (SNPs) were analyzed. We identified 436 variable positions along OsHV-1 μVar A genome: 268 and 59 were specific to Atl and Med, respectively, and 109 were common to both experimental infections as compared to OsHV-1 μVar A ([Figure 3A](#F3){ref-type="fig"} and [Supplementary Tables S4](#TS4){ref-type="supplementary-material"}, [S5](#TS5){ref-type="supplementary-material"}).

![Distinct heterogeneous viral populations within Atlantic and Mediterranean experimental infections. **(A)** Venn diagram representation of the number of specific and common SNPs within each experimental infection. The frequency distribution of SNPs for specific **(B)** and common **(C)** SNPs between Atlantic and Mediterranean experimental infections is illustrated in histograms. SNPs are binned at 5% intervals along the *x*-axis, and the number of SNPs in each bin is indicated on the *y*-axis. **(D)** Common SNPs are ordered according to decreasing variant frequency in Atlantic experimental infection and plotted for the same position in Mediterranean experimental infection. Black and white dots correspond to SNPs with different or similar variant frequencies (difference \< 5%), respectively.](fmicb-11-01579-g003){#F3}

Variants were binned (5% intervals) according to their frequency ([Figures 3B,C](#F3){ref-type="fig"}). Variants specific to Atl may be subdivided into three groups, minor (47%; frequency \< 25%) intermediate (48.1%; 25% ≤ frequency ≤ 75%) and major variants (4.9%; frequency \> 75%) ([Figure 3B](#F3){ref-type="fig"}, upper panel). Variants specific to Med segregated in 2 main clusters, minor (62.7%) and major variants (35.6%) ([Figure 3B](#F3){ref-type="fig"}, lower panel). This difference in distribution of variant frequency from Atl and Med was also observed for variants common to both experimental infections ([Figure 3C](#F3){ref-type="fig"}). Indeed, the percentages of minor and intermediate variants were higher in Atl than in Med (minor: 23.9% and 17.4%, respectively, intermediate: 49.5 and 21.1%, respectively). Conversely, the percentage of major variants was lower in Alt than in Med (26.6 and 60.5%, respectively).

Finally, we compared the variant frequency between Atl and Med for each of the common SNPs on the 109 positions spread all over the OsHV-1 μVar genome ([Figure 3D](#F3){ref-type="fig"} and [Supplementary Table S6](#TS6){ref-type="supplementary-material"}). On these 109 common SNPs, 49.5% (54 SNPs) had the same variant frequency (difference in variant frequency \< 5%) and 50.5% (55 SNPs) had different variant frequency (ranging from 5.1 to 88.2%; median of 42.9%).

Altogether, these results show that the viral populations collected in the two environments (Atlantic and Mediterranean) are different from each other but also different from the OsHV-1 μVar A genome used as reference. Interestingly, the viral population from Med have a reduced genetic diversity compared to the one from Atl. Indeed, whereas viral population from Med had less SNPs, 52.3% of them correspond to major variants with 9.5% of fixation (variant frequency 100%) whereas in Atl, there were only 11.1% of major variants with 1.3% of fixation ([Supplementary Tables S4](#TS4){ref-type="supplementary-material"}, [S5](#TS5){ref-type="supplementary-material"}).

Atlantic and Mediterranean OsHV-1 μVar Viral Populations Bear Different Membranes Proteins {#S3.SS3}
------------------------------------------------------------------------------------------

We further examined the distribution of all variants that occurred in ORFs and we found that 299 SNPs (out of 436) were located in ORFs. Among them, 99 correspond to synonymous SNPs and 200 to nonsynonymous SNPs (nsSNPs) that could be divided into 191 missense variants, 5 stop lost, 4 stop gained, and 2 start lost ([Figure 4](#F4){ref-type="fig"}). The comparison of specific SNPs for each experimental infection revealed that for the Atlantic viral population, 76 ORFs (59.4%) carry at least one nsSNPs compared to only 53 ORFs (41.4%) for the viral populations from the Mediterranean.

![Impact of the 200 nonsynonymous SNPs on the sequence of OsHV-1 μVar ORFs. Stacked barplot indicates the number of nonsynonymous SNPs (*x*-axis) located in each OsHV-1 ORF (*y*-axis). Each color indicates a specific mutation effect as indicated at the bottom of the figure. Each line is related to one of the expressed OsHV-1 ORFs. ORF colors (left side) correspond to a functional annotation of the proteins that they encode.](fmicb-11-01579-g004){#F4}

We then focused on the nature of the proteins encoded by the ORFs carrying nsSNPs. The most represented ORF group, carrying 55.4% of the nsSNPs, encodes proteins of unknown functions (44 ORFs). The second most represented ORF group encodes membrane-related proteins (membrane and transmembrane proteins, glycosylated or not) and 15 out of 19 ORFs encoding this type of proteins carry 23.3% of the nsSNPs ([Table 1](#T1){ref-type="table"}). Some ORFs carry numerous nsSNPs (ORF32, ORF54 and ORF103) and were differentially mutated in the two experimental infections. For instance, ORF54 which is predicted to encode a transmembrane glycoprotein of 807 aa carries 8 nsSNPs, 7 of which are specific to Atl. Among these 7 snSNPs, 2 induce a stop_lost, which increases the protein size by 39 aa, and 5 correspond to missense-variants. These mutations in ORFs could impact protein functions.

###### 

ORFs encoding membrane related proteins carrying nsSNPs.

  **ORF (GenBank accession \#)**   **ORF size (in bp)**   **Protein size (in aa)**   **Protein putative function**             **SNPs position**   **Type of variation**   **Allel frequency (in %)**   **Experimental infection**   **Impact on protein**   
  -------------------------------- ---------------------- -------------------------- ----------------------------------------- ------------------- ----------------------- ---------------------------- ---------------------------- ----------------------- ---------------------
                                                                                                                                                                           **Atl.**                     **Med.**                                             
  **ORF16 (ASK05544.1)**           **231**                **76**                     **Membrane protein**                      21,892              missense_variant        43.00                        0.00                         Atlantic                His22Gln
                                                                                                                               21,917              **stop_gained**         0.00                         **76.09**                    **Mediterranean**       **deletion 45 aa**
  ORF22 (ASK05550.1)               4899                   1632                       Transmembrane protein, 1 helix            29,343              missense_variant        21.46                        0.00                         Atlantic                Val64Leu
  ORF25 (ASK05553.1)               666                    221                        Transmembrane glycoprotein, 1 helix       39,333                                      41.52                        0.00                         Atlantic                Arg216Lys
  ORF32                            1659                   552                        Transmembrane glycoprotein, 1 helix       47,348              missense_variant        51.63                        94.55                        Common                  Ser10Phe
                                                                                                                               48,888                                      14.04                        10.18                        Common                  Leu523Phe
                                                                                                                               48,884                                      10.54                        6.78                         Common                  Trp522Leu
                                                                                                                               48,885                                      11.18                        7.28                         Common                  Trp522Phe
                                                                                                                               48,220                                      0.00                         95.11                        Mediterranean           Asp301Asn
                                                                                                                               48,283                                      0.00                         11.20                        Mediterranean           Asp322Asn
  ORF41 (ASK05566.1)               2922                   973                        Transmembrane protein, 1 helix            56,584              missense_variant        48.05                        0.00                         Atlantic                Asp866Asn
                                                                                                                               54,968                                      0.00                         19.09                        Mediterranean           Val327Asp
  ORF54 (ASK05581.1)               2424                   807                        Transmembrane glycoprotein, 1 helix       80,895              missense_variant        100.00                       99.75                        Common                  Ser202Gly
                                                                                                                               82,296                                      7.61                         0.00                         Atlantic                Asp669Asn
                                                                                                                               80,297                                      45.50                        0.00                         Atlantic                Asn2Lys
                                                                                                                               80,299                                      42.72                        0.00                         Atlantic                Thr3Lys
                                                                                                                               80,301                                      15.96                        0.00                         Atlantic                Val4Ile
                                                                                                                               80,302                                      11.41                        0.00                         Atlantic                Val4Asp
                                                                                                                               82,714              stop_lost               25.36                        0.00                         Atlantic                addition 39 aa
                                                                                                                               82,715                                      26.20                        0.00                         Atlantic                addition 39 aa
  ORF59 (ASK05586.1)               3243                   1080                       Transmembrane glycoprotein, 1 helix       87,730              missense_variant        8.58                         0.00                         Atlantic                Asp332Asn
                                                                                                                               87,319                                      5.97                         0.00                         Atlantic                Glu195Lys
  ORF65.1                          1263                   420                        Transmembrane glycoprotein, 1 helix       95,619              missense_variant        59.47                        100.00                       Common                  Thr201Arg
                                                                                                                               95,887                                      8.90                         0.00                         Atlantic                Glu112Lys
                                                                                                                               96,057                                      9.74                         0.00                         Atlantic                Asp55Gly
                                                                                                                               95,820                                      0.00                         93.58                        Mediterranean           Ser134Leu
  ORF68 (ASK05592.1)               2082                   693                        Transmembrane protein, 1 helix            103,523             missense_variant        41.37                        0.00                         Atlantic                Asp394Tyr
  ORF77 (ASK05600.1)               3795                   1264                       Transmembrane glycoprotein, 2 helix       115,467             missense_variant        40.22                        0.00                         Atlantic                Arg3Gln
                                                                                                                               117,243                                     7.41                         0.00                         Atlantic                Gln595Arg
                                                                                                                               115,875                                     7.46                         0.00                         Atlantic                Thr139Met
  ORF80 (ASK05603.1)               351                    116                        Transmembrane glycoprotein, 1 helix       123,511             missense_variant        99.93                        99.96                        Common                  Tyr77Phe
  ORF88 (ASK05611.1)               2247                   748                        Transmembrane glycoprotein, 1 helix       130,979             missense_variant        99.95                        99.90                        Common                  Val381Gly
                                                                                                                               130,997                                     99.92                        99.86                        Common                  Thr387Met
                                                                                                                               131,902                                     7.63                         0.00                         Atlantic                Asp689Asn
  ORF103 (ASK05626.1)              1272                   423                        Transmembrane protein, 4 helix            153,070             missense_variant        40.57                        0.00                         Atlantic                Glu43Lys
                                                                                                                               153,223                                     47.84                        94.06                        Common                  Gly94Arg
                                                                                                                               153,224                                     48.52                        94.31                        Common                  Gly94Glu
                                                                                                                               153,848                                     22.79                        0.00                         Atlantic                Ser302Leu
                                                                                                                               153,151                                     0.00                         13.53                        Mediterranean           Glu70Lys
  ORF111 (ASK05633.1)              870                    289                        Transmembrane glycoprotein, 5 helix       168,846             missense_variant        8.04                         0.00                         Atlantic                Ser51Leu
                                                                                                                               168,853                                     43.81                        94.32                        Common                  Glu49Lys
  **ORF114 (ASK05636.1)**          **969**                **321**                    **Transmembrane glycoprotein, 1 helix**   171,530             **stop_gained**         **84.63**                    0.00                         **Atlantic**            **Deletion 307 aa**
                                                                                                                               171,532             p.Ile16Lys              89.40                        0.00                         Atlantic                Ile16Lys
  ORFIN.4 (ASK05572.1)             981                    326                        Transmembrane glycoprotein, 1 helix       61,244              missense_variant        99.96                        99.93                        Common                  Phe166Ile
                                                                                                                               61,725              missense_variant        9.08                         0.00                         Atlantic                Ser326Leu
                                                                                                                               61,728              stop_lost               11.40                        0.00                         Atlantic                Addition 3 aa
                                                                                                                               61,729                                      12.40                        0.00                         Atlantic                Addition 3 aa

The ORFs in bold correspond to variants of the stop_gained type.

More interestingly, two ORFs carry stop_gained mutations at high frequency. The first one, found specifically in Med at a frequency of 76.1%, truncates the ORF16, predicted to encode a transmembrane protein, by replacing the 31st amino acid by a stop codon removing 58.4% of the protein. The second one, found specifically in Atl at a frequency of 84.6%, truncates the ORF114 by replacing the 15th amino acid by a stop codon removing 95.3% of the protein. Amino acid sequence analysis predict that ORF114 encodes a transmembrane glycoprotein with a transmembrane helix (aa 13--35) and a glycosylated extracellular domain (aa 36--322), both of which are truncated by the mutation ([Supplementary Figure S1](#PS1){ref-type="supplementary-material"}). Interestingly, size variations of these ORFs have already been reported for the different OsHV-1 genomes available. The most striking size variations are observed for the protein encoded by the ORF114 with 494 aa in OsHV-1 ([@B27]) 322 in OsHV-1 μVar A ([@B18]) and 282 in OsHV-1-PT ([@B1]). Surprisingly, whereas the three proteins are almost 100% identical on their C-terminal part (281 aa), solely the protein encoded by OsHV-1 μVar A contains a transmembrane helix ([Supplementary Figure S2](#PS2){ref-type="supplementary-material"}; [@B18]).

Oyster Families Are Infected by Distinct Viral Populations in a Same Environment {#S3.SS4}
--------------------------------------------------------------------------------

In order to determine if the different oyster families are infected or not by the same viral populations within each experimental infection, we compared, independently in experimental infection, the number and frequency of SNPs between oyster families with intermediates and/or susceptible phenotypes.

For the Atl, we compared the four oyster families with susceptible (F11) and intermediate (F9, F32, and F44) phenotypes. We observed that families with intermediate phenotypes contained a similar number of variants whereas the susceptible family F11 contained a larger number of variants ([Figure 5A](#F5){ref-type="fig"} and [Supplementary Table S7](#TS7){ref-type="supplementary-material"}). This difference could be related to the fact that susceptible families have a higher viral load than the families with intermediate phenotype. The higher number of viral reads obtained in susceptible oysters could have facilitated the identification of viral variants. However, each family with intermediate phenotypes (F9, F32, and F44) contained specific SNPs which were not found in F11, which suggests viral populations differ between oyster families. We also identified 148 SNPs common to the 4 families. The analysis of F11/32/44 revealed that their variant frequency are equally scattered with 12--15% of minor variants, 68--71% of intermediate variants and 17% of major variants ([Figure 5B](#F5){ref-type="fig"} and [Supplementary Table S7](#TS7){ref-type="supplementary-material"}). For the F9 we observed a majority of minor variant (45%), followed by 30 and 26% of intermediate and major variants, respectively ([Figure 5B](#F5){ref-type="fig"} and [Supplementary Table S7](#TS7){ref-type="supplementary-material"}). We also compared the variant frequency between the four oyster families for each of the common SNPs on the 148 positions spread all over the OsHV-1 μVar genome ([Figure 5C](#F5){ref-type="fig"}). On these 148 common SNPs, only 12.2% (32) have the same variant frequency in the four families (difference in variant frequency \< 5%). A two by two comparison of the four families revealed that the percentage of SNPs having the same variant frequency ranked from 29% (43 SNPs for F9/F11) to 46% (68 SNPs for F32/F44) ([Supplementary Table S8](#TS8){ref-type="supplementary-material"}). These results show that the four families of oyster do not contain the same viral populations.

![Distinct heterogeneous viral populations infect oyster families during Atlantic experimental infection. **(A)** Venn diagram representation of the number of specific and common SNPs in viral populations infecting each susceptible or intermediate oyster families (F9/11/32/44). **(B)** The frequency distribution of common SNPs across the 4 infected families is illustrated by a histogram. SNPs are binned at 5% intervals along the *x*-axis, and the number of SNPs in each bin is indicated on the *y*-axis. **(C)** Common SNPs are ordered according to decreasing variant frequency in F11 family and plotted for the same position in F32, F44, and F9 families. Black and white dots correspond to SNPs with different or similar variant frequencies (difference \< 5%), respectively.](fmicb-11-01579-g005){#F5}

For the Med, we compared the two oyster families with susceptible phenotypes (F11 and F32) and observed that they contain a similar number of variants with 111 common and 18 and 39 specific to F11 and F32, respectively ([Figure 6A](#F6){ref-type="fig"}). Variant frequency analysis of the 111 common SNPs revealed that they are equally distributed in the three groups of variants ([Figure 6B](#F6){ref-type="fig"} and [Supplementary Table S9](#TS9){ref-type="supplementary-material"}). Indeed, there was 6.3 and 8.1% of minor variants in F11 and F32, respectively, 16.2 and 15.3% of intermediate variants in F11 and F32, respectively, and 77.5 and 76.6% of major variants in F11 and F32, respectively. We also compared the variant frequency between the two oyster families for each of the common SNPs on the 111 positions spread all over the OsHV-1 μVar genome ([Figure 6C](#F6){ref-type="fig"} and [Supplementary Table S10](#TS10){ref-type="supplementary-material"}). On these 111 common SNPs, 47 have the same variant frequency (difference in variant frequency \< 5%). For the other SNPs, it is interesting to note that the variant frequency of 91% of them (58 out of 64) is higher in F11 than in F32. In addition, the number of fixed SNPs (variant frequency 100%) is almost twice higher in F11 (41) than in F32 (24). These results also showed that F11 and F32 do not contain the same viral populations in this environment.

![Distinct heterogeneous viral populations infect oyster families during Mediterranean experimental infection. **(A)** Venn diagram representation of the number of specific and common SNPs in viral populations infecting each susceptible oyster families (F11/32). **(B)** The frequency distribution of common SNPs across the 2 infected families is illustrated by a histogram. SNPs are binned at 5% intervals along the *x*-axis, and the number of SNPs in each bin is indicated on the *y*-axis. **(C)** Common SNPs are ordered according to decreasing variant frequency in F11 family and plotted for the same position in F32 family. Black and white dots correspond to SNPs with different or similar variant frequencies (difference \< 5%), respectively.](fmicb-11-01579-g006){#F6}

Altogether, these results show that in as same environment, each oyster family is infected by distinct viral populations.

Discussion {#S4}
==========

In the present study, we analyzed the OsHV-1 diversity in oysters with different genetic backgrounds exposed to two different environments (Atlantic and Mediterranean oyster farming areas during an episode of POMS). The two infection experiments led to contrasting survival phenotypes between oyster families within and between environments. As OsHV-1 infection is the first and necessary step to induce POMS ([@B28]) we focused our study on the diversity of OsHV-1 populations infecting oysters.

Viral sequences found in oyster tissues differed between environments with an overall number of 436 SNP variants identified. Sequences differed from the OsHV-1 μVar A genome (originating from the English Channel, Normandy coast, France) used here as reference ([@B18]). Moreover, viral populations from the Atlantic and the Mediterranean differed (i) by 268 SNPs specific to the Atlantic environment, 59 specific to the Mediterranean environment, and also (ii) by variant frequencies within the 109 SNPs common to both environments. SNP abundance was twice higher in the Atlantic environment with a fixation rate seven times lower compared to the Mediterranean environment, which suggests that the viral populations infecting oysters in the Atlantic are more diversified than in the Mediterranean Sea. One possible environmental reason for this difference is that in the Atlantic, oyster farms are located in the Brest harbor, which is colonized by a huge population of wild oysters cohabitating with farmed oysters. In contrast in the Mediterranean Thau lagoon, farmed oysters represent the majority of the oyster population ([@B47]; [@B57]). The wild oyster populations of the Atlantic are likely to be reservoirs of viruses with a higher genetic diversity than the cultured populations of the Thau lagoon, as indicated by previous studies showing a lower viral diversity in hatchery−reared oysters relative to wild individuals ([@B75]). In full support of these observations, a higher host genetic diversity is expected to generate a higher viral diversity since viruses are obligatory cellular parasites, which implies that the virus and the host partners reciprocally affect each other's evolution ([@B41]). Regardless of the origin of this diversity, our analysis revealed that the OsHV-1 μVar diversity along French coasts is higher than previously described ([@B20]). This result is consistent with the high diversity also observed for this virus along the Italian Adriatic Sea coast ([@B19]).

To further analyze the different viral populations infecting the different oyster families, we compared the OsHV-1 diversity between each oyster genetic background in a same environment (Atl or Med). We observed that (i) each oyster family had its own subset of specific variants and (ii) the majority of common variants displayed distinct frequencies between families. Therefore different families (with intermediates and/or susceptible phenotypes) are infected by distinct viral populations. This suggests that each biparental oyster family, with its own genetic background, is compatible with a subset of the viral variants. In other words, each oyster genotype could constitute a transmission bottleneck that may retain a part of the viral diversity present in the viral population. Although the role of genetic bottlenecks in virus transmission is well documented, their impact on viral genetic diversity and host-virus coevolution are difficult to predict ([@B53]). Indeed, it depends on numerous parameters like the virus type, the size of the initial viral population, the size of the bottleneck, as well as the relative impact of within and between host processes ([@B81]). Genome-wide analyses recently highlighted the role played by inter- and intra-host herpesvirus genomic diversity in colonization of the host (new organ or host shift) and disease manifestations ([@B49]; [@B67]; [@B2]). Defining the oyster and OsHV-1 factors that determine the transmission bottleneck would be an important step to understand the different levels of infectivity observed between the different oyster families. To reach this end, it would be necessary to study, within each individual oyster, the dynamics of OsHV-1 diversity.

In addition to the presence of distinct viral populations in the two environments that differentially infect each oyster genetic backgrounds, we also observed that oyster families may display a different survival phenotype according to the infectious environment they experienced. Three oyster families F9, F32, and F44, which had an intermediate phenotype during the Atlantic experimental infection, were found susceptible or resistant during the Mediterranean experimental infection. This observation suggests that some oyster genotypes are more susceptible to some viral variants than to others. Several parameters such as the environment, viral genomic feature and host genetics might explain these differences in disease outcome.

By investigating SNPs found in viral populations specific to each environment, we uncovered some differences in viral proteins and more specifically in membrane-related proteins. In mammalian *herpesviridae* (i.e., cytomegalovirus) membrane-related proteins and particularly glycoproteins play a critical role in virus entry into host cell or escape of the host immunity and it has been proposed that the intense selection playing on these proteins could be driven by the interaction with the host immune system ([@B36]; [@B43]). Here we found that 15 out of 19 ORFs encoding this type of proteins in the OsHV-1 genome, contain at least one nsSNP and most of these mutations are specific to Atlantic or Mediterranean viral populations. Two of these ORFs (ORF16 and ORF114) are particularly interesting since (i) they correspond to stop-gain mutations inducing large protein deletion and (ii) each of them is specific to a viral population. Previous studies already pointed out mutations in membrane proteins and suggested that they could be involved in the higher virulence of the μVar genotype compared to the reference OsHV-1 genotype ([@B51]; [@B18]; [@B20]). Interestingly, two other ORFs encoding membrane-related proteins (ORF 25 and ORF 41), which are differentially mutated in Atlantic and Mediterranean viral populations, appeared to be involved in interaction between OsHV-1 and host cells ([@B52]). We hypothesize that the mutations in membrane related proteins described in this study could have functional consequences on host-virus interactions and could be linked to the difference in susceptibility observed for the families F9, F32, and F44 when they were confronted to disease originated from Atlantic or Mediterranean environments.

The observed phenotypic heterogeneity could also be related to the genetic background of oysters. Numerous studies already showed the genetic basis for resistance to OsHV-1μVar in oyster ([@B10], [@B9]; [@B22]; [@B38]). Recent data further showed that oyster genetic selection for survival to one variant of OsHV-1 may not greatly increase survival to another variant ([@B31]) suggesting that the genetic architecture of resistance to OsHV-1 infection in oyster is differentially structured according to viral genotypes involved.

Conclusion {#S5}
==========

In conclusion, the results obtained revealed the presence of OsHV-1 populations, distinct from the OsHV-1μVar A genome, are different in the Atlantic and Mediterranean environments but also differentially infect oyster families. These inter-environment and inter-family genetic variations might be indicative of a host-pathogen co-evolutionary process. Although OsHV-1 genotypic variations have been extensively described in the literature, it is the first time to our knowledge, that a potential genotype-genotype interaction is highlighted in oyster-OsHV-1 interactions. The next challenges will be to combine phenotypic measures of viral impact in experimental infections with whole viral genomes sequencing and comparative genomics techniques to make headway toward a better understanding of how specific genetic differences in OsHV-1 and oyster influence the outcome of infection and how this may shape the distribution of genetic variation within and between viral populations. This study highlights the need for future investigations on co-evolutionary dynamics of oyster-OsHV-1 interactions taking into account viral diversity, viral mutation rate through space and time, mechanisms of adaptation in changing environments that will have to be considered in future strategies to mitigate POMS and shape next oyster selective breeding programs.
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